Robert C. Friedmann

Statistics

Publications

Citations

381

H-Index

Active since

1983

Affiliations

Novartis (Switzerland)(Current)

Robert C. Friedmann is an author at Novartis (Switzerland) specializing in medicinal chemistry, structure-activity relationship analysis, and pharmacology.

Publications per year

1983–2004

Publications

Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists

John E. Francis, William D. Cash, Stacy Psychoyos et al. · Journal of Medicinal Chemistry · 1988 · 153 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones

John E. Francis, William D. Cash, Beverly S. Barbaz et al. · Journal of Medicinal Chemistry · 1991 · 74 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Pharmaceutical impurity identification: A case study using a multidisciplinary approach

Karen M. Alsante, Peter Boutros, Michel Couturier et al. · Journal of Pharmaceutical Sciences · 2004 · 50 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +14

Azatetralone synthesis via regioselective Grignard coupling and Parham cyclization

George J. Quallich, Darrell E. Fox, Robert C. Friedmann et al. · The Journal of Organic Chemistry · 1992 · 37 citations

Natural Sciences, Chemistry, Analytical Chemistry +5

Angiotensin converting enzyme inhibitors: N-Substituted monocyclic and bicyclic amino acid derivatives

James L. Stanton, Norbert Gruenfeld, Joseph E. Babiarz et al. · Journal of Medicinal Chemistry · 1983 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–5 of 6